NEUP Neuphoria Therapeutics Inc.

Nasdaq www.neuphoriatx.com


$ 6.05 $ 2.19 (54.07 %)    

Friday, 24-Oct-2025 19:59:34 EDT
QQQ $ 617.50 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.25 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.59 $ -1.27 (-0.34 %)
$ 6.24
$ 6.30
$ 5.75 x 1
$ 6.08 x 200
$ 5.66 - $ 8.44
$ 2.90 - $ 21.40
83,669,632
na
14.71M
$ 0.48
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 09-29-2025 06-30-2025 10-K
2 05-20-2025 03-31-2025 10-Q
3 02-14-2025 12-31-2024 10-Q
4 11-14-2024 09-30-2024 10-Q
5 09-30-2024 06-30-2024 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

AFFIRM-1 trial did not meet primary endpoint or secondary endpointsCompany to conduct strategic review of portfolio and busines...

Core News & Articles

Maxim Group analyst Jason McCarthy maintains Neuphoria Therapeutics (NASDAQ:NEUP) with a Buy and raises the price target fro...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION